AATB Names C5 Biomedical CEO Tim Maye Among 50 Honorees Marking the Association's 50th Anniversary

amniotic membrane allograftsPositive

AI Analysis

Summary

C5 Biomedical CEO Tim Maye was named among 50 honorees by AATB marking the association's 50th anniversary. Maye has nearly three decades of experience in the field and spent six years chairing AATB's Standards Committee.

Importance:2/10

Sentiment:

0.30

awardrecognition50th anniversaryFDA-registeredAATB-accreditedleadership

Read the original article

Published by PR Newswire Biotech on October 6, 2026 3:54 PM

Read Original